Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-23-010331
Filing Date
2023-02-10
Accepted
2023-02-10 16:41:20
Documents
5
Effectiveness Date
2023-02-10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea173100-s8_citiuspharm.htm S-8 129962
2 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea173100ex5-1_citiuspharm.htm EX-5.1 8218
3 CONSENT OF WOLF & COMPANY, P.C ea173100ex23-1_citiuspharm.htm EX-23.1 2524
4 FORM OF NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AWARD AGREEMENT ea173100ex99-2_citiuspharm.htm EX-99.2 59753
5 FILING FEE TABLE ea173100ex-fee_citiuspharm.htm EX-FILING FEES 11848
  Complete submission text file 0001213900-23-010331.txt   213501
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-269703 | Film No.: 23612799
SIC: 2834 Pharmaceutical Preparations